- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Surgery Partners Inc (SGRY)
Surgery Partners Inc stock price live, this page displays NASDAQ SGRY stock exchange data. View the SGRY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Surgery Partners Inc real time stock price chart below.
What Is the Surgery Partners Inc Stock Price Today?
The Surgery Partners Inc stock price today is 14.87.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the NASDAQ stock exchange.
Is Surgery Partners Inc a Good Stock to Buy?
Determining whether Surgery Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGRY quote. (ISIN: US86881A1007)
What Is the Surgery Partners Inc Stock Price Today?
The Surgery Partners Inc stock price today is 14.87.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the NASDAQ stock exchange.
Is Surgery Partners Inc a Good Stock to Buy?
Determining whether Surgery Partners Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SGRY quote. (ISIN: US86881A1007)
14.87
+0.14(+0.95%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.59
15.04
52 wk Range
11.41
24.18
Earnings results expected in 12 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.5915.04
52 wk Range
11.4124.18
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SGRY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
18.68
Upside
+25.63%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
- Form DEF 14A Surgery Partners Inc For: 17 April
- Investing.com
- Form DEF 14A Surgery Partners Inc For: 15 April
- Investing.com
- Form DEF 14A Surgery Partners Inc For: 17 April
- Investing.com
- Form DEF 14A Surgery Partners Inc For: 15 April
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners Inc SWOT Analysis
Strategic Resilience | Surgery Partners reaffirms 2025 guidance after ending take-private talks, showcasing confidence in its business strategy amid healthcare sector challenges |
Financial Landscape | Analysts project EPS growth from $0.61 to $0.80, with price targets ranging from $24 to $35, reflecting mixed views on the company's profitability potential |
Operational Excellence | Delve into Surgery Partners' physician recruitment success and efficiency improvements, key drivers for expanding service offerings and mitigating rising costs |
Market Dynamics | Explore how Surgery Partners navigates stable surgical demand and pricing pressures, positioning itself in the evolving outpatient care landscape |
Surgery Partners Inc Earnings Call Summary for Q2/2025
- Surgery Partners beats Q2 2025 estimates: EPS $0.17 vs $0.16 forecast, revenue $826M vs $819.45M expected; stock up 3.51% pre-market
- Q2 net revenue up 8.4% YoY, adjusted EBITDA grew 9% to $129M; company maintains 'GOOD' Financial Health score per InvestingPro analysis
- FY2025 guidance: revenue $3.3B-$3.45B, adjusted EBITDA $555M-$565M; targeting 6% same-facility growth and $200M in acquisitions
- Focus on expanding surgical facilities, enhancing procedural capabilities through technology investments and partnerships
- Risks include market saturation, regulatory changes, economic downturns affecting elective procedures, and competition from hospital-based centers
Last Updated: 2025-08-05, 12:34 p/m
Read Full TranscriptCompare SGRY to Peers and Sector
Metrics to compare | SGRY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSGRYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −24.7x | 13.7x | −0.5x | |
PEG Ratio | −0.45 | 0.23 | 0.00 | |
Price/Book | 1.1x | 2.7x | 2.6x | |
Price / LTM Sales | 0.6x | 2.1x | 3.2x | |
Upside (Analyst Target) | 22.2% | 30.2% | 45.2% | |
Fair Value Upside | Unlock | 24.3% | 6.4% | Unlock |
Analyst Ratings
9 Buy
3 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 18.68
(+25.63% Upside)
Earnings
Latest Release
Mar 02, 2026
EPS / Forecast
0.12 / 0.30
Revenue / Forecast
885M / 866.79M
People Also Watch
FAQ
What Is the Surgery Partners Inc (SGRY) Stock Price Today?
The Surgery Partners Inc stock price today is 14.87 USD.
What Stock Exchange Does Surgery Partners Inc Trade On?
Surgery Partners Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Surgery Partners Inc?
The stock symbol for Surgery Partners Inc is "SGRY."
What Is the Surgery Partners Inc Market Cap?
As of today, Surgery Partners Inc market cap is 1.90B USD.
What Is Surgery Partners Inc's Earnings Per Share (TTM)?
The Surgery Partners Inc EPS (TTM) is -0.61.
When Is the Next Surgery Partners Inc Earnings Date?
Surgery Partners Inc will release its next earnings report on May 05, 2026.
From a Technical Analysis Perspective, Is SGRY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Surgery Partners Inc Stock Split?
Surgery Partners Inc has split 0 times.
How Many Employees Does Surgery Partners Inc Have?
Surgery Partners Inc has 16000 employees.
What is the current trading status of Surgery Partners Inc (SGRY)?
As of Apr 23, 2026, Surgery Partners Inc (SGRY) is trading at a price of 14.87 USD, with a previous close of 14.73 USD. The stock has fluctuated within a day range of 14.59 USD to 15.04 USD, while its 52-week range spans from 11.41 USD to 24.18 USD.
What Is Surgery Partners Inc (SGRY) Price Target According to Analysts?
The average 12-month price target for Surgery Partners Inc is 18.68 USD, with a high estimate of 25 USD and a low estimate of 14 USD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +25.63% Upside potential.
What Is the SGRY Premarket Price?
SGRY's last pre-market stock price is 14.52 USD. The pre-market share volume is 110.00, and the stock has decreased by -0.21, or -1.43%.
What Is the SGRY After Hours Price?
SGRY's last after hours stock price is 15.01 USD, the stock has decreased by 0.28, or 1.90%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.